Physician profile
Jenna Fahey
NPI 1376120832
$549.43
in general payments reported to CMS, 2019-2025
17 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.04 · 2023: $121 · 2024: $178 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $166.51 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $58.12 | 2023-2024 | |
| Itamar Medical INC | $50.18 | 2024 | Watchpatone |
| Viiv Healthcare Company | $48.40 | 2025 | Apretude |
| Lilly USA, LLC | $28.01 | 2023-2025 | Mounjaro |
| Resmed Corp | $22.67 | 2025 | |
| Astellas Pharma US INC | $20.08 | 2023 | Veozah |
| Sanofi-Aventis U.S. LLC | $19.26 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $18.35 | 2023 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $17.01 | 2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $15.15 | 2023 | Invega Sustenna |
| Mayne Pharma Commercial LLC | $15.03 | 2023 | |
| Merck Sharp & Dohme LLC | $14.82 | 2023 | Gardasil 9, Vaxneuvance |
| Genentech USA, INC. | $14.30 | 2022 | |
| Pfizer INC. | $14.19 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.79 | 2025 | |
| Neos Therapeutics, LP | $13.56 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Fahey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.